APOTHEEK HEYLEN
ActiveAPOTHEEK HEYLEN has been active since 1974 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €736k and a net result of €226k. Equity remains stable across the filed fiscal years (±2.3% per year). Its solvency ranks better than 43% of 10310 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2025
76
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability81▲+1
Solvency56▲+9
Growth58=
Track record100
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €55k at 30 days acceptable
Liquidity ample (current ratio 2.05 against 1.57 in 2024; short-term debt: 20.8% and cash: 15.4% of total assets), but 69.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
30.9%
Return on assets
9.5%
Age of the figures
9 mo
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025Equity per financial year
1819202122232425
2018 to 2025 · latest year €736k
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-08-2026, 24 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
24 d late
2024
12 d late
2023
2 d early
2022
29 d late
2021
23 d late
2020
24 d late
2019
14 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
19-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€736k▲ 44.2%
2024 · €510k
2018: €803k
2019: €918k
2020: €979k
2021: €1.02M
2022: €1.24M
2023: €316k
2024: €510k
2018 → 2025
Total assets
€2.38M▲ 4.8%
2024 · €2.27M
2018: €1.08M
2019: €1.17M
2020: €1.33M
2021: €1.52M
2022: €2.31M
2023: €3.03M
2024: €2.27M
2018 → 2025
Net result
€226k▲ 14.1%
2024 · €198k
2018: €132k
2019: €145k
2020: €161k
2021: €141k
2022: €216k
2023: €97k
2024: €198k
2018 → 2025
Working capital
€522k▲ 82.5%
2024 · €286k
2018: €704k
2019: €852k
2020: €929k
2021: €1.16M
2022: €1.12M
2023: €65k
2024: €286k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€1.02M-€1.24M▲ 21.2%€316k▼ 74.4%€510k▲ 61.3%€736k▲ 44.2%
Operating result€193k-€245k▲ 27.1%€145k▼ 40.8%€177k▲ 21.7%€312k▲ 76.8%
Net result€141k-€216k▲ 52.9%€97k▼ 55.3%€198k▲ 105%€226k▲ 14.1%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 77% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.38M
Fixed assets
€1.37M▼ 8.0%
Current assets
€1.02M▲ 29.0%
Equity and liabilities €2.38M
Equity
€736k▲ 44.2%
Debt
€1.65M▼ 6.6%
The debt ratio falls from 77.6% to 69.1%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€435k▲
2024 · €313k
Cash flow
€348k▲
2024 · €334k
Solvency
30.9%▲
2024 · 22.4%
Current ratio
2.05▲
2024 · 1.57
Quick ratio
1.55▲
2024 · 1.05
Debt / equity
2.24▼
2024 · 3.46
ROE
30.7%▼
2024 · 38.8%
ROA
9.5%▲
2024 · 8.7%
Interest coverage
11.13▲
2024 · 7.35
Debt
€1.65M▼
2024 · €1.76M
Debt ≤ 1 year
€495k▼
2024 · €503k
Debt > 1 year
€1.15M▼
2024 · €1.26M
Income taxes
€73k▲
2024 · €45k
Staff costs
€206k▼
2024 · €229k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€2.27M€2.38M▲
Fixed assets21/28€1.48M€1.37M▼
Tangible fixed assets22/27€1.48M€1.36M▼
Land and buildings22€808k€791k▼
Plant, machinery and equipment23€662k€60k▼
Furniture and vehicles24€6k-
Other tangible fixed assets26-€506k
Financial fixed assets28€9k€9k=
Current assets29/58€789k€1.02M▲
Stocks and contracts in progress3€259k€251k▼
Stocks30/36€259k€251k▼
Amounts receivable within one year40/41€267k€287k▲
Trade receivables40€231k€234k▲
Other amounts receivable41€36k€53k▲
Current investments50/53€25k€45k▲
Cash at bank and in hand54/58€203k€366k▲
Deferred charges and accrued income490/1€35k€68k▲
Equity and liabilities
Total equity and liabilities10/49€2.27M€2.38M▲
Equity10/15€510k€736k▲
Contributions10/11€19k€19k=
Reserves13€492k€717k▲
Distributable reserves133€492k€717k▲
Profit (loss) carried forward14€0-
Amounts payable17/49€1.76M€1.65M▼
Amounts payable after more than one year17€1.26M€1.15M▼
Financial debts170/4€1.26M€1.15M▼
Amounts payable within one year42/48€503k€495k▼
Current portion of amounts payable after more than one year42€105k€108k▲
Trade debts44€155k€346k▲
Suppliers440/4€155k€346k▲
Taxes, remuneration and social security45€14k€42k▲
Taxes450/3€0€3k▲
Remuneration and social security454/9€14k€39k▲
Other amounts payable47/48€229k-
Accrued charges and deferred income492/3€4k€3k▼
Income statement
Code20242025
Non-recurring operating income76A-€29k
Remuneration, social security and pensions62€229k€206k▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€136k€122k▼
Other operating charges640/8€659€7k▲
Non-recurring operating charges66A€18k-
Gross operating margin9900€561k€647k▲
Operating profit (loss)9901€177k€312k▲
Financial income75/76B€108k€26k▼
Recurring financial income75€108k€26k▼
Financial charges65/66B€43k€39k▼
Recurring financial charges65€43k€39k▼
Profit (loss) for the period before taxes9903€242k€299k▲
Income taxes67/77€45k€73k▲
Profit (loss) for the period9904€198k€226k▲
Profit (loss) for the period to be appropriated9905€198k€226k▲
Appropriation of the result
Profit (loss) to be appropriated9906€198k€226k▲
Transfer from equity791/2€0-
Transfer to equity691/2€194k€226k▲
To other reserves6921€194k€226k▲
Profit to be distributed694/7€4k-
Return on contributions (dividend)694€0-
Employees696€4k-
Social balance
Average headcount (FTE)90873.83.5▼
The notes to these accounts (12 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
24-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 24 days late
2025
31-12
Financial
Highest result since 2018net €226k ▲14.1%
Operating result €312k, net result €226k, both a record.
12-08
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 12 days late
2024
31-12
Financial
Equity above €500kEq €510k ▲61.3%
7 profitable years in a row build equity to €510k.
29-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial
Weakest financial yearnet €97k ▼55.3%
Net result drops to €97k, the lowest in the series; recovery starts the following year.
29-08
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 29 days late
2022
23-08
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 23 days late
2021
31-12
Financial
Equity above €1MEq €1.02M ▲4.2%
4 profitable years in a row build equity to €1.02M.
24-08
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 24 days late
2020
14-08
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 14 days late
2019
20-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 20 days late
2018
07-08
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema · 7 days late
2017
21-08
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 21 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
no sitting director, no change since 2025
We have established no sitting directors for this company. We derive directors from published Gazette acts; while there are none, or none read, nothing appears here. That does not mean the company has none: the CBE keeps its own list of function holders, which we do not read.
01-12-2025
Resigned as Director
21-01-2022
Resigned as Director
Location & real-estate footprint
Registered office, Nijlen · 1 establishment unit since 1974
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Bouwelsesteenweg 72560 NijlenGround area
3,093 m²
Building footprint
406 m²
Volume, LiDAR
25 m³
Parcel 12026D0929/00A000, Flanders · tallest building 7.3 m. Linked by address, not a title deed.
1 establishment unit
APOTHEEK HEYLEN
since 19742.009.766.754
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 12026D0929/00A000 | Flanders | 3,093 m² | 1 · 406 m² | 7.3 m |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2025 · 2 entries · 4,850 EUR awarded · 4,850 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 2 | 4,850 EUR | 4,850 EUR |
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
Hinderpremie bij openbare werken
Similar companies · same sector, comparable size
APOTHEEK DE SCHRIJVER
BE 0437.172.862
Rijkevorsel · Eq €736k
PHARMACIE GAYE Saint-Cosme
BE 0438.978.646
Chimay · Eq €735k
Apotheek VAN der ELST Filip
BE 0442.717.797
Geraardsbergen · Eq €736k
APOTHEEK MEEUSEN
BE 0475.582.387
Beerse · Eq €735k
APOTHEEK TWEE NETEN
BE 0461.936.764
Lier · Eq €734k
Of 5,223 companies in sector 47730 we hold annual accounts for 3,862. 3,202 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded12-03-1974
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
Sources
Crossroads Bank for EnterprisesNational Bank · 49 filingsAddress and cadastre registers
Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.